Boston Scientific Corp: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
8.11 Bil |
| Income |
-2.38 Bil |
| Net Profit Margin |
-29.33% |
| Return on Equity |
-16.41% |
| Debt/Equity Ratio |
0.45 |
|
| Revenue/Share |
5.38 |
| Earnings/Share |
-1.59 |
| Book Value/Share |
8.80 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 2,010.0 | 2,047.0 | 2,086.0 |
| 2nd Qtr | 2,074.0 | 2,024.0 | 2,071.0 |
| 3rd Qtr | 2,025.0 | 1,978.0 | 2,048.0 |
| 4th Qtr | NA | 2,002.0 | 2,152.0 |
| Total | 6,109.0 | 8,051.0 | 8,357.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.01 | $0.22 | $0.08 |
| 2nd Qtr | $0.10 | $0.07 | $0.08 |
| 3rd Qtr | -$0.06 | -$0.04 | -$0.18 |
| 4th Qtr | NA | -$1.62 | -$0.31 |
| Total | $0.03 | -$1.37 | -$0.33 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 99% | NA | --- |
| 2nd Qtr | NA | -68% | 0% |
| 3rd Qtr | NA | NA | NA |
| 4th Qtr | NA | -3,950% | -72% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | 175% |
| 2nd Qtr | 43% | -12% |
| 3rd Qtr | -50% | 78% |
| 4th Qtr | NA | -423% |
advertisement
Recent News